{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,22]],"date-time":"2025-12-22T22:05:51Z","timestamp":1766441151785,"version":"3.37.3"},"reference-count":34,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2019,8,1]],"date-time":"2019-08-01T00:00:00Z","timestamp":1564617600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100000190","name":"University of Alberta","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000190","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005049","name":"Natural Science and Engineering Research Council of Canada","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005049","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jpharmsci.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pharmaceutical Sciences"],"published-print":{"date-parts":[[2019,8]]},"DOI":"10.1016\/j.xphs.2019.03.016","type":"journal-article","created":{"date-parts":[[2019,3,21]],"date-time":"2019-03-21T13:53:22Z","timestamp":1553176402000},"page":"2698-2707","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"title":["Delivery and Biodistribution of Traceable Polymeric Micellar Diclofenac in the Rat"],"prefix":"10.1016","volume":"108","author":[{"given":"Hanan","family":"Al-Lawati","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohammad R.","family":"Vakili","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Afsaneh","family":"Lavasanifar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Surur","family":"Ahmed","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fakhreddin","family":"Jamali","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.xphs.2019.03.016_bib1","doi-asserted-by":"crossref","first-page":"232","DOI":"10.2165\/00003495-198427030-00004","article-title":"Non-steroidal anti-inflammatory drugs. Current status and rational therapeutic use","volume":"27","author":"Hart","year":"1984","journal-title":"Drugs"},{"issue":"Suppl 4","key":"10.1016\/j.xphs.2019.03.016_bib2","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1093\/rheumatology\/32.suppl_4.35","article-title":"Non-steroidal anti-inflammatory drugs","volume":"32","author":"Blower","year":"1993","journal-title":"Br J Rheumatol"},{"issue":"5","key":"10.1016\/j.xphs.2019.03.016_bib3","doi-asserted-by":"crossref","first-page":"821","DOI":"10.18433\/J3VW2F","article-title":"Adverse effects of nonsteroidal antiinflammatory drugs: an update of gastrointestinal, cardiovascular and renal complications","volume":"16","author":"Harirforoosh","year":"2014","journal-title":"J\u00a0Pharm Pharm Sci"},{"issue":"2","key":"10.1016\/j.xphs.2019.03.016_bib4","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1016\/j.xphs.2017.09.020","article-title":"Drug-disease interaction: effect of inflammation and nonsteroidal anti-inflammatory drugs on cytochrome P450 metabolites of arachidonic acid","volume":"107","author":"Aghazadeh-Habashi","year":"2018","journal-title":"J\u00a0Pharm Sci"},{"key":"10.1016\/j.xphs.2019.03.016_bib5","series-title":"Sudden Cardiac Death: Epidemiology, Genetics and Predictive\/Prevention Strategies","article-title":"Non-Steroidal anti-inflammatory drugs and increased risk of sudden cardiac death","author":"Hwang","year":"2013"},{"issue":"3","key":"10.1016\/j.xphs.2019.03.016_bib6","doi-asserted-by":"crossref","first-page":"191","DOI":"10.2165\/00003088-199936030-00002","article-title":"Pharmacokinetics of nonsteroidal anti-inflammatory drugs in synovial fluid","volume":"36","author":"Day","year":"1999","journal-title":"Clin Pharmacokinet"},{"issue":"12","key":"10.1016\/j.xphs.2019.03.016_bib7","doi-asserted-by":"crossref","first-page":"2985","DOI":"10.1185\/030079907X242584","article-title":"Persistence of NSAIDs at effect sites and rapid disappearance from side-effect compartments contributes to tolerability","volume":"23","author":"Brune","year":"2007","journal-title":"Curr Med Res Opin"},{"issue":"10","key":"10.1016\/j.xphs.2019.03.016_bib8","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1111\/j.1440-1681.2006.04464.x","article-title":"Extent of renal effect of cyclo-oxygenase-2-selective inhibitors is pharmacokinetic dependent","volume":"33","author":"Harirforoosh","year":"2006","journal-title":"Clin Exp Pharmacol Physiol"},{"issue":"7","key":"10.1016\/j.xphs.2019.03.016_bib9","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1002\/jat.1342","article-title":"Effect of inflammation on kidney function and pharmacokinetics of COX-2 selective nonsteroidal anti-inflammatory drugs rofecoxib and meloxicam","volume":"28","author":"Harirforoosh","year":"2008","journal-title":"J\u00a0Appl Toxicol"},{"issue":"8","key":"10.1016\/j.xphs.2019.03.016_bib10","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1023\/A:1008365716693","article-title":"Pegylated liposomal doxorubicin (doxil): reduced clinical cardiotoxicity in patients reaching or exceeding cumulative doses of 500 mg\/m2","volume":"11","author":"Safra","year":"2000","journal-title":"Ann Oncol"},{"issue":"1","key":"10.1016\/j.xphs.2019.03.016_bib11","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/j.taap.2013.06.002","article-title":"Evaluation of the pharmacokinetics and cardiotoxicity of doxorubicin in rat receiving nilotinib","volume":"272","author":"Zhou","year":"2013","journal-title":"Toxicol Appl Pharmacol"},{"key":"10.1016\/j.xphs.2019.03.016_bib12","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1007\/s10787-017-0344-1","article-title":"Cardiovascular effect of inflammation and nonsteroidal anti-inflammatory drugs on renin-angiotensin system in experimental arthritis","volume":"25","author":"Asghar","year":"2017","journal-title":"Inflammopharmacology"},{"issue":"13","key":"10.1016\/j.xphs.2019.03.016_bib13","doi-asserted-by":"crossref","first-page":"1633","DOI":"10.1001\/jama.296.13.jrv60011","article-title":"Cardiovascular risk and inhibition of cyclooxygenase: a systematic review of the observational studies of selective and nonselective inhibitors of cyclooxygenase 2","volume":"296","author":"McGettigan","year":"2006","journal-title":"JAMA"},{"issue":"1","key":"10.1016\/j.xphs.2019.03.016_bib14","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1517\/17425247.3.1.139","article-title":"Polymeric micelles for drug delivery","volume":"3","author":"Aliabadi","year":"2006","journal-title":"Expert Opin Drug Deliv"},{"issue":"1","key":"10.1016\/j.xphs.2019.03.016_bib15","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.jconrel.2013.07.026","article-title":"The accelerated blood clearance (ABC) phenomenon: clinical challenge and approaches to manage","volume":"172","author":"Abu Lila","year":"2013","journal-title":"J\u00a0Control Release"},{"issue":"2","key":"10.1016\/j.xphs.2019.03.016_bib16","doi-asserted-by":"crossref","first-page":"109","DOI":"10.2174\/2211738504666160428154616","article-title":"Polymeric micelles for the delivery of diclofenac and its ethyl ester derivative","volume":"4","author":"Al-Lawati","year":"2016","journal-title":"Pharm Nanotechnol"},{"issue":"26","key":"10.1016\/j.xphs.2019.03.016_bib17","doi-asserted-by":"crossref","first-page":"9419","DOI":"10.1021\/ma0613786","article-title":"Novel self-associating poly (ethylene oxide)-b lock-poly (\u03b5-caprolactone) block copolymers with functional side groups on the polyester block for drug delivery","volume":"39","author":"Mahmud","year":"2006","journal-title":"Macromolecules"},{"key":"10.1016\/j.xphs.2019.03.016_bib18","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.biomaterials.2017.08.001","article-title":"Traceable PEO-poly(ester) micelles for breast cancer targeting: the effect of core structure and targeting peptide on micellar tumor accumulation","volume":"144","author":"Garg","year":"2017","journal-title":"Biomaterials"},{"year":"2008","series-title":"Polymer Microscopy","author":"Sawyer","key":"10.1016\/j.xphs.2019.03.016_bib19"},{"issue":"1-2","key":"10.1016\/j.xphs.2019.03.016_bib20","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.ijpharm.2010.01.015","article-title":"Novel self-associating poly(ethylene oxide)-b-poly(epsilon-caprolactone) based drug conjugates and nano-containers for paclitaxel delivery","volume":"389","author":"Shahin","year":"2010","journal-title":"Int J Pharm"},{"issue":"2","key":"10.1016\/j.xphs.2019.03.016_bib21","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.jchromb.2005.10.045","article-title":"Efficient high performance liquid chromatograph\/ultraviolet method for determination of diclofenac and 4'-hydroxydiclofenac in rat serum","volume":"830","author":"Kaphalia","year":"2006","journal-title":"J\u00a0Chromatogr B Analyt Technol Biomed Life Sci"},{"issue":"3","key":"10.1016\/j.xphs.2019.03.016_bib22","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/j.cmpb.2010.01.007","article-title":"PKSolver: an add-in program for pharmacokinetic and pharmacodynamic data analysis in Microsoft Excel","volume":"99","author":"Zhang","year":"2010","journal-title":"Comput Methods Programs Biomed"},{"issue":"3","key":"10.1016\/j.xphs.2019.03.016_bib23","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1208\/s12248-010-9185-1","article-title":"DDSolver: an add-in program for modeling and comparison of drug dissolution profiles","volume":"12","author":"Zhang","year":"2010","journal-title":"AAPS J"},{"key":"10.1016\/j.xphs.2019.03.016_bib24","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.actbio.2015.06.017","article-title":"Rational design of block copolymer micelles to control burst drug release at a nanoscale dimension","volume":"24","author":"Soleymani Abyaneh","year":"2015","journal-title":"Acta Biomater"},{"key":"10.1016\/j.xphs.2019.03.016_bib25","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.colsurfb.2015.05.015","article-title":"Polymeric micelles based on poly(ethylene oxide) and alpha-carbon substituted poly(varepsilon-caprolactone): an in\u00a0vitro study on the effect of core forming block on polymeric micellar stability, biocompatibility, and immunogenicity","volume":"132","author":"Garg","year":"2015","journal-title":"Colloids Surf B Biointerfaces"},{"issue":"1","key":"10.1016\/j.xphs.2019.03.016_bib26","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1097\/00007691-198810010-00016","article-title":"Longer plasma half-life for procainamide utilizing a very sensitive high performance liquid chromatography assay","volume":"10","author":"Jamali","year":"1988","journal-title":"Ther Drug Monit"},{"issue":"6","key":"10.1016\/j.xphs.2019.03.016_bib27","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1007\/BF01080872","article-title":"Pharmacokinetics and bioavailability of diclofenac in the rat","volume":"19","author":"Peris-Ribera","year":"1991","journal-title":"J\u00a0Pharmacokinet Biopharm"},{"issue":"1","key":"10.1016\/j.xphs.2019.03.016_bib28","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.jconrel.2008.03.015","article-title":"Formulation of a geldanamycin prodrug in mPEG-b-PCL micelles greatly enhances tolerability and pharmacokinetics in rats","volume":"129","author":"Xiong","year":"2008","journal-title":"J\u00a0Control Release"},{"key":"10.1016\/j.xphs.2019.03.016_bib29","doi-asserted-by":"crossref","first-page":"4089","DOI":"10.2147\/IJN.S33607","article-title":"Preparation and in\u00a0vivo pharmacokinetics of curcumin-loaded PCL-PEG-PCL triblock copolymeric nanoparticles","volume":"7","author":"Feng","year":"2012","journal-title":"Int J Nanomedicine"},{"issue":"4","key":"10.1016\/j.xphs.2019.03.016_bib30","doi-asserted-by":"crossref","first-page":"338","DOI":"10.2174\/138920012800166490","article-title":"Pharmacokinetics and disposition of nanomedicine using biodegradable PEG\/PCL polymers as drug carriers","volume":"13","author":"Wang","year":"2012","journal-title":"Curr Drug Metab"},{"issue":"1-2","key":"10.1016\/j.xphs.2019.03.016_bib31","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.ijpharm.2008.07.008","article-title":"Pharmacokinetic evaluation of indomethacin ethyl ester-loaded nanoencapsules","volume":"363","author":"Cattani","year":"2008","journal-title":"Int J Pharm"},{"issue":"1","key":"10.1016\/j.xphs.2019.03.016_bib32","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/0306-3623(76)90028-8","article-title":"Mechanisms of action of anti-inflammatory drugs","volume":"7","author":"Brune","year":"1976","journal-title":"Gen Pharmacol"},{"issue":"2","key":"10.1016\/j.xphs.2019.03.016_bib33","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.nantod.2014.04.008","article-title":"Challenges associated with penetration of nanoparticles across cell and tissue barriers: a review of current status and future prospects","volume":"9","author":"Barua","year":"2014","journal-title":"Nano Today"},{"issue":"35","key":"10.1016\/j.xphs.2019.03.016_bib34","doi-asserted-by":"crossref","first-page":"7251","DOI":"10.1016\/j.biomaterials.2005.05.042","article-title":"Polymeric micelles for the solubilization and delivery of cyclosporine A: pharmacokinetics and biodistribution","volume":"26","author":"Aliabadi","year":"2005","journal-title":"Biomaterials"}],"container-title":["Journal of Pharmaceutical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022354919301625?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022354919301625?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,9,23]],"date-time":"2019-09-23T22:43:33Z","timestamp":1569278613000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022354919301625"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,8]]},"references-count":34,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2019,8]]}},"alternative-id":["S0022354919301625"],"URL":"https:\/\/doi.org\/10.1016\/j.xphs.2019.03.016","relation":{},"ISSN":["0022-3549"],"issn-type":[{"type":"print","value":"0022-3549"}],"subject":[],"published":{"date-parts":[[2019,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Delivery and Biodistribution of Traceable Polymeric Micellar Diclofenac in the Rat","name":"articletitle","label":"Article Title"},{"value":"Journal of Pharmaceutical Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.xphs.2019.03.016","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 American Pharmacists Association\u00ae. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}